Results 101 to 106 of about 106,762 (106)

In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency

Pharmaceuticals
Robert Wodtke, Kristof Zarschler, Markus Laube   +2 more
exaly  

ENTEROBACTER CLOACAE SUBSP. DISSOLVENS STRAIN TJ1812 IN ACRYLAMIDE BIODEGRADATION

2020
exaly  

A new neuroprotective candidate TJ1 targeting amyloidogenesis in 5xFAD Alzheimer’s disease mice

International Immunopharmacology
Jin-Ming Gao, Jiang-Jiang Tang
exaly  

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors

Case Medical Research
exaly  

S myth, J ohn ( c .1570–1612)

2011
exaly  

Abstract 3298: Preclinical development of TJ106, a potent biparatopic dual payload ADC targeting HER2 for the treatment of Enhertu-resistant tumors

Cancer Research
exaly